vTv Therapeutics Inc.
NASDAQ:VTVT · NASDAQ Capital Market
+$1.18 today
Vol 0.07M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+115.41%
Period High
$42.72
Period Low
$14.00
Latest
$33.86
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Fortress Biotech, Inc.
NASDAQ:FBIO
$92.02M
OS Therapies Incorporated
AMEX:OSTX
$75.71M
Gain Therapeutics, Inc.
NASDAQ:GANX
$71.66M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$71.19M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$66.38M
MiNK Therapeutics, Inc.
NASDAQ:INKT
$59.88M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$50.19M
CervoMed Inc.
CRVO
$22.68M
Werewolf Therapeutics, Inc.
HOWL
$18.52M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest VTVT filing?
The latest filing shown is DEFA14A dated Jun 10, 2026.
How many recent filings does VTVT have?
Intrinsic Alpha currently shows 20 recent filings for VTVT.
Explore More
Continue the stock analysis
Jump to another research area for this company.